http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2001520198-A

Outgoing Links

Predicate Object
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01D2221-10
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5094
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-363
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01D21-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01D21-262
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01D21-01
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L26-0042
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01D17-047
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01D21-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01D17-0217
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-75
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-43
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K1-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/B01D21-01
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L26-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/B01D21-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/B01D17-02
filingDate 1998-10-16^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2001-10-30^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-2001520198-A
titleOfInvention Preparation of growth factor-enriched fibrinogen concentrate from platelet-rich plasma
abstract (57) [Summary]nIncreased fibrinogen yield is obtained by adding a precipitant to plasma having a high platelet concentration, for example, platelet-rich plasma. The precipitant is any of several known, including polyethylene glycol and ammonium sulfate. Platelet-rich plasma is obtained in a preferred embodiment by subjecting the plasma to a "soft spin" centrifugation at about 580G. To separate the anticoagulated whole blood into platelet-rich plasma components and red blood cells, preferably automatic multi-stage tilting and multi-speed centrifuges are used. The proteins, preferably fibrinogen, FXIII and FVIII, in the platelet-rich plasma component are precipitated, and the proteins and platelets are then concentrated by further centrifugation.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2011508771-A
priorityDate 1997-10-17^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP22775
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP84122
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP81070
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24538
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID373926
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID14069
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID100271720
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID395837
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID100302404
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID403875
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID178
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID2157
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID1969
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID473838
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID447827115
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID302470
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID422199

Showing number of triples: 1 to 48 of 48.